Document and Entity Information Document Information [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock [Member] Class A Ordinary Shares This member stands for redeemable warrants Redeemable Warrants [Member] Warrants Document Information [Line Items] Document Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address State Or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Condensed Consolidated Balance Sheets Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash Cash and cash equivalents Other Prepaid Expense, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Assets Total assets Liabilities and Equity [Abstract] Liabilities, Redeemable Noncontrolling Interest and Shareholders' Equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Total accounts payable and accrued expenses Liabilities, Current Total current liabilities Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent Private placement warrants Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 9) Temporary Equity [Abstract] Convertible preferred shares Redeemable Noncontrolling Interest, Equity, Carrying Amount Redeemable noncontrolling interest Stockholders' Equity Attributable to Parent [Abstract] Shareholders' Equity: Preferred Stock, Value, Issued Preferred shares, $0.0001 par value, 1,000,000 authorized as of March 31, 2024, and December 31, 2023; -0- issued and outstanding as of March 31, 2024, and December 31, 2023 Common Stock, Value, Issued Class A Ordinary shares, $0.0001 par value, 300,000,000 authorized, 43,593,678 issued and outstanding as of March 31, 2024, and December 31, 2023 Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Total Zura Bio Limited shareholders' equity Equity, Attributable to Noncontrolling Interest Noncontrolling interest Noncontrolling interest balance Equity, Including Portion Attributable to Noncontrolling Interest Balance Balance Total shareholders' equity Liabilities and Equity Total liabilities, redeemable noncontrolling interest, and shareholders' equity Temporary Equity, Shares Outstanding Balance (Shares) Balance (Shares) Series A-1 convertible preferred shares outstanding (in shares) Preferred Stock, Par or Stated Value Per Share Preferred shares, par value per share (in dollars per share) Preferred Stock, Shares Authorized Preferred shares authorized (in shares) Preferred shares, shares authorized Preferred Stock, Shares Issued Preferred shares issued (in shares) Preferred Stock, Shares Outstanding Preferred shares outstanding (in shares) Common Stock, Par or Stated Value Per Share Class A ordinary shares, par value per share (in dollars per share) Common Stock, Shares Authorized Class A ordinary shares authorized (in shares) Common Stock, Shares, Issued Class A ordinary shares issued (in shares) Common Stock, Shares, Outstanding Ending Balance (in Shares) Beginning Balance (in shares) Class A ordinary shares outstanding (in shares) Condensed Consolidated Statements of Operations Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Other Nonoperating Income (Expense) [Abstract] Other (income)/expense, net: Other Nonoperating Income (Expense) Other (income)/expense Investment Income, Interest Interest income Fair Value Adjustment of Warrants Change in fair value of private placement warrants Change in fair value of private placement warrants Gain from the change in fair value of the private placement warrants Amount of expense (income) related to adjustment to fair value of warrant liability note payable. Fair Value Adjustment of Note Payable Change in fair value of note payable Nonoperating Income (Expense) Total other (income)/expense, net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Income Tax Expense (Benefit) Income tax benefit Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net loss before redeemable noncontrolling interest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Net loss attributable to redeemable noncontrolling interest Net loss Temporary Equity, Accretion to Redemption Value, Adjustment Accretion of redeemable noncontrolling interest to redemption value Accretion of redeemable noncontrolling interest to redemption value Accretion of redeemable noncontrolling interest to redemption value Value of adjustment from redemption value to carrying value of temporary equity during the period. Temporary Equity, Redemption Value To Carrying Value Adjustment Adjustment of redeemable noncontrolling interest from redemption value to carrying value Adjustment of redeemable noncontrolling interest from redemption value to carrying value Net Income (Loss) Available to Common Stockholders, Basic Net loss attributable to Class A Ordinary Shareholders of Zura Earnings Per Share, Basic Net loss per share attributable to Class A Ordinary Shareholders of Zura, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share attributable to Class A Ordinary Shareholders of Zura, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted-average Class A Ordinary Shares used in computing net loss per share attributable to Class A Ordinary Shareholders of Zura, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average Class A Ordinary Shares used in computing net loss per share attributable to Class A Ordinary Shareholders of Zura, diluted (in shares) Condensed Consolidated Statements of Changes in Redeemable Noncontrolling Interest, Convertible Preferred Shares, and Shareholders' Equity (Deficit) Equity Components [Axis] Equity Component [Domain] Noncontrolling Interest [Member] Noncontrolling interest Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Information by temporary equity.. Temporary Equity [Axis] The components of temporary equity. Temporary Equity [Domain] This member stands for redeemable noncontrolling Interest. Redeemable Noncontrolling Interest [Member] Redeemable Noncontrolling Interest This member stands for convertible referred shares. Convertible Preferred Shares [Member] Convertible Preferred Shares Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents the information pertaining to License agreement with Lilly. License Agreement with Lilly [Member] License agreement with Lilly Increase (Decrease) in Temporary Equity [Roll Forward] Convertible Preferred Shares Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Balance Balance Value of new stock issued for license during the period. Temporary Equity, Stock Issued During Period, Value, New Issues for License Issuance of Series A-1 convertible preferred shares as license compensation Issuance of Series A-1 convertible preferred shares as license compensation Number of new stock issued for license during the period. Temporary Equity, Stock Issued During Period, Shares, New Issues for License Issuance of Series A-1 convertible preferred shares as license compensation (in shares) Stock Issued During Period, Value, Conversion of Convertible Securities Conversion of Series A-1 convertible preferred shares to Class A Ordinary Shares in connection with Business Combination Conversion of Series A-1 convertible preferred shares to Class A Ordinary Shares in connection with Business Combination Stock Issued During Period, Shares, Conversion of Convertible Securities Conversion of Series A-1 convertible preferred shares to Class A Ordinary Shares in connection with Business Combination (in shares) Conversion of Series A-1 convertible preferred shares to Class A Ordinary Shares in connection with Business Combination (in shares) The value of issued call right. Value Of Issued Call Right Stone Peach Call Right issued to noncontrolling interest Value of issued call right Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Deficit Stock Issued During Period, Value, Acquisitions Issuance of Class A Ordinary Shares in connection with Business Combination, including PIPE Investment, Forward Purchase Investment, and Backstop Shares, net of $4.0 million of transaction costs Stock Issued During Period, Shares, Acquisitions Issuance of Class A Ordinary Shares in connection with Business Combination, including PIPE Investment, Forward Purchase Investment, and Backstop Shares (in shares) Value of stock issued pursuant to settle research and development license consideration liability during the period. Stock Issued During Period, Value, Research and Development License Consideration Liability Aggregate fair value of the shares issued Issuance of Class A Ordinary Shares to settle research and development license consideration liability Number of shares of stock issued during the period pursuant to settle research and development license consideration liability. Stock Issued During Period, Shares, Research and Development License Consideration Liability Issuance of ordinary shares to settle research and development license consideration liability Issuance of Class A Ordinary Shares to settle research and development license consideration liability (in shares) Adjustments to Additional Paid in Capital, Warrant Issued Reclassification of public warrant liability to equity APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Share-based compensation expense Stock Issued During Period, Shares, New Issues Issuance of shares (in shares) Business Combination, Acquisition Related Costs Transaction costs The number of exchange ratio for ordinary shares pursuant to the business combination. Exchange Ratio for Ordinary Shares Pursuant to the Business Combination Exchange ratio for Class A ordinary shares pursuant to the business combination Condensed Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss before redeemable noncontrolling interest Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Amount of anti-dilution share issuance compensation. Anti-Dilution Share Issuance Compensation Anti-dilution share issuance compensation Share-Based Payment Arrangement, Noncash Expense Share-based compensation Amount of expense (income) related to adjustment to fair value of share-based payment liability. Fair Value Adjustment of Share-based Payment Liability Change in fair value of share-based payment liability Foreign Currency Transaction Gain (Loss), before Tax Foreign exchange transaction (gain)/loss Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Payments to Acquire in Process Research and Development Purchase of research and development license Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities Repayments of Notes Payable Settlement of note payable Settlement of note payable Proceeds from Issuance of Common Stock Proceeds from issuance of Class A Ordinary Shares upon Closing of Business Combination The amount of payment of deferred transaction costs. Payment of Deferred Transaction Costs Payment of deferred transaction costs Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net (decrease)/increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental Disclosure of Non-Cash Investing and Financing Activities The amount of payment of deferred transaction costs. Conversion of Series A One Convertible Preferred Shares for Ordinary Shares Conversion of Series A-1 convertible preferred shares for Class A Ordinary Shares Non cash, value of adjustment from redemption value to carrying value of temporary equity during the period. Temporary Equity, Redemption Value To Carrying Value Adjustment, Non-cash Activities Adjustment of redeemable noncontrolling interest from redemption value to carrying value Capital Expenditures Incurred but Not yet Paid Purchase of property and equipment included in accounts payable and accrued expenses The amount for conversion of Series A-1 convertible preferred shares for Ordinary Shares. Assumption of Public and Private Placement Warrants in Connection with Business Combination Assumption of public and private placement warrants in connection with Business Combination The amount for reclassification of public warrant liability to equity. Reclassification of Public Warrant Liability to Equity Reclassification of public warrant liability to equity The amount for settlement of research and development license consideration liability. Settlement of Research and Development License Consideration Liability Settlement of research and development license consideration liability The amount for transaction costs include in accounts payable. Transaction Costs Include in Accounts Payable Transaction costs included in accounts payable and accrued expenses The amount for reclassification of deferred transaction costs to additional paid-in capital. Reclassification of Deferred Transaction Costs to Additional Paid-in Capital Reclassification of deferred offering costs to additional paid-in capital Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and Description of Business Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Accounts Payable and Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accounts Payable and Accrued Expenses License Agreements Asset Acquisition [Text Block] License Agreements No definition available. Shareholders' Equity The entire disclosure for temporary equity and shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income Temporary Equity Disclosure and Stockholders' Equity Note Disclosure [Text Block] Shareholders' Equity No definition. Warrants The entire disclosure of derivative warrant liabilities. Derivative Warrant Liabilities Disclosure [Text Block] Warrants Share-Based Compensation Share-Based Payment Arrangement [Text Block] Share-Based Compensation Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies. Redeemable Noncontrolling Interest The entire disclosure of temporary equity. Temporary Equity [Text Block] Redeemable Noncontrolling Interest Subsequent Events Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of Presentation and Principles of Consolidation Disclosure of accounting policy for significant accounting policies. Significant of Accounting, Policy [Policy Text Block] Significant Accounting Policies Consolidation, Policy [Policy Text Block] Use of Estimates Disclosure of accounting policy for risks and uncertainties. Risks and Uncertainties Policy [Policy Text Block] Risks and Uncertainties Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share New Accounting Pronouncements, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potentially dilutive securities not included in the calculation of the diluted net loss per common share because to do so would be anti-dilutive Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule of financial assets and liabilities measured at fair value on a recurring basis Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of changes in the estimated fair value Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of accounts payable and accrued expenses The tabular disclosure of shares reserved for issuance. Summary of Shares Reserved For Issuance [Table Text Block] Schedule of shares reserved for issuance Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of number of warrants outstanding, exercise price, and expiration dates Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Represents the member information pertaining to Market-Based Performance Share Options. Market-Based Performance Share Options [Member] Market-Based Share Options Plan Name [Axis] Plan Name [Domain] Represents information pertaining to 2023 equity incentive plan. Equity Incentive Plan 2023 [Member] Equity Incentive Plan 2023 Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted-average assumptions were used to estimate the fair value Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of company's share option activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of restricted share units Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of share-based Compensation Expense Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Warrant [Member] Shares issuable upon exercise of the Warrants to purchase Class A Ordinary Shares Shares issuable upon exercise of options to purchase Class A Ordinary Shares Represents the information pertaining to Z33 Series Seed Preferred Shares. Z33 Series Seed Preferred Shares [Member] Shares issuable upon exercise of Z33 Series Seed Preferred Shares Put Right Restricted Stock Units (RSUs) [Member] Restricted Share Units Restricted Stock [Member] Restricted Share Awards Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Summary of Significant Accounting Policies Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Restricted share units Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Fair Value, Inputs, Level 2 [Member] Level 2 Asset Class [Axis] Asset Class [Domain] Cash Equivalents [Member] Cash equivalents Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Represents the information pertaining to Private Placement Warrants. Private Placement Warrants [Member] Private placement warrants Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements Assets, Fair Value Disclosure Financial assets Financial Liabilities Fair Value Disclosure Financial liabilities Amount of transfers of liabilities measured on a recurring basis between Level 1 and Level 2. Fair Value, Liability, Level 1 to Level 2 Transfers, Amount Transfers between level 1 and level 2 Amount of transfers of liabilities measured on a recurring basis between Level 2 and Level 3. Transfers between level 2 and level 3 Transfers level 2 and level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Transfers into or out of level 3 Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value, Recurring and Nonrecurring [Table] Short-Term Debt, Type [Axis] Short-Term Debt, Type [Domain] Represents information pertaining to note payable. Note Payable [Member] Note payable Counterparty Name [Axis] Counterparty Name [Domain] Represents information pertaining to Hydra, LLC. Hydra, LLC [Member] Hydra Short-Term Debt [Line Items] Proceeds from Notes Payable Proceeds form issuance of note Debt Instrument, Face Amount Face amount of note Represents the information pertaining to research and development license consideration. Research and Development License Consideration [Member] Research and development license consideration Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurements The number of ordinary shares agreed to issue upon the closing of the business combination. Number of Ordinary Shares Agreed to Issue Upon the Closing of the Business Combination Number of Class A ordinary shares agreed to issue upon the closing of the business combination The number of Z33 series seed preferred shares to be issued if the business combination was not consummated. Issuance of Z33 Series Seed Preferred Shares if the Business Combination was Not Consummated Issuance of Z33 series seed preferred shares if the business combination was not consummated Share Price Fair value per share Fair value per stock issued pursuant to settle research and development license consideration liability during the period. Fair Value Per Share, Value, Research and Development License Consideration Liability Fair value per issued share Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Summary of changes in the estimated fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Ending balance Beginning balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Remeasurement of the Note to settlement value upon the Closing of the Business Combination Change in fair value The amount of gain or loss on the remeasurement of the research and development license consideration liability. Gain or Loss on the Remeasurement of the Research and Development License Consideration Liability Loss on the remeasurement of the research and development license consideration liability Carrying value as of the balance sheet date of obligations incurred through that date and payable for payroll costs, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued 2023 Lilly License Costs Accrued 2023 Lilly License costs Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development expense. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Research And Development Expense Current Accrued research and development costs Accounts Payable, Current Accounts payable Carrying value as of the balance sheet date of obligations incurred through that date and payable for bonus costs, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Bonus Cost Current Accrued bonus Other Accrued Liabilities, Current Other accrued expenses Asset Acquisition [Table] Asset Acquisition [Axis] Asset Acquisition [Domain] Represents the member information pertaining to License Agreement and a Series A-1 Subscription and Shareholder's Agreement with Pfizer. License Agreement and a Series A-1 Subscription and Shareholder's Agreement with Pfizer [Member] Agreement with Pfizer Represents the information pertaining to Lonza license agreement. Lonza License Agreement [Member] Lonza milestone payment Balance Sheet Location [Axis] Balance Sheet Location [Domain] Accounts Payable and Accrued Liabilities [Member] Accounts Payable and Accrued Liabilities Asset Acquisition [Line Items] License Agreements Shareholders' Equity Payments to Acquire Productive Assets Amount of cash transferred Upfront cash payment The number of shares of equity interests issued or issuable to acquire entity. Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Number of Shares Number of shares transferred Represents the number of development and regulatory milestone payments in asset acquisition. Asset Acquisition, Consideration, Number of Development And Regulatory Milestone Payments Number of development and regulatory milestone payments Represents the maximum amount of development and regulatory milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition. Asset Acquisition, Consideration, Maximum Development And Regulatory Milestone Payments Based On Respective Thresholds Of Net Sales Of Products Maximum amount of development and regulatory milestone payments Represents the maximum amount of sales milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition. Asset Acquisition, Consideration, Maximum Sales Milestone Payments Based On Respective Thresholds Of Net Sales Of Products Maximum amount of sales milestone payments Represents the maximum percentage of payment of annual earned royalty at a marginal royalty rate. Asset Acquisition, Consideration, Maximum Percentage of Payment of Annual Earned Royalty At A Marginal Royalty Rate Maximum annual earned royalty at a marginal royalty rate The amount of development milestone recognized as a component of research and development. Amount of Development Milestone Recognized as a Component of Research and Development Development Of research and development Amount of milestone payment to be made annually under the terms of agreement. Annual Milestone Payment, Due And Payable Annual milestone payment, due and payable Represents the information pertaining to Stone Peach Properties, LLC. Stone Peach Properties, LLC [Member] Stone Peach Properties, LLC Stone Peach Common Class A [Member] Class A Ordinary shares Represents the percentage of right but not the obligation for purchase of issued shares, maximum percentage. Right But Not the Obligation for Purchase of Issued Shares, Maximum Percentage Right but not the obligation for purchase of issued shares, maximum percentage The per share amount of purchase price per share. Purchase Price Per Share Purchase price per share The threshold period from the date of agreement for purchase of issued shares in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Threshold Period From the Date of Agreement for Purchase of Issued Shares Threshold period from the date of agreement for purchase of issued shares Represents the percentage of he right but not the obligation to sell the issued shares, maximum percentage. Right But Not the Obligation to Sell the Issued Shares, Maximum Percentage Right but not the obligation to sell the issued shares, maximum percentage The per share amount of selling price per share. Selling Price Per Share Selling price per share The amount of obligation to pay upon the completion of financing. Amount of Obligation to Pay Upon the Completion of Financing Amount of obligation to pay upon the completion of financing The minimum gross proceeds from financing for obligation to pay. Minimum Gross Proceeds From Financing for Obligation to Pay Minimum gross proceeds from financing for obligation to pay The amount of contingent payments due. Contingent Payment Due Contingent payments due The number of shares issued on exercise of call options. Number of Shares Issued on Exercise of Call Option The number of shares in exchange for exercise of Put Right. Number of Shares On Exercise of Put Right Number of shares in exchange for exercise of put Right. Represents the information pertaining to BAFFX17, Ltd. BAFFX17, Ltd [Member] BAFFX17, Ltd Consolidated Entities [Axis] Consolidated Entities [Domain] Represents the information pertaining to ZB17 LLC. ZB17 LLC [Member] ZB17 LLC The percentage of the call options exercised. Percentage of the Call Options Exercised Percentage of the call options exercised Asset Acquisition, Contingent Consideration, Liability Amount payable upon receipt of certain know-how, data, information and materials The issued call right to purchase, percentage of fully-diluted equity. Issued Call Right To Purchase, Percentage Of Fully-Diluted Equity Issued call right to purchase, percentage of fully-diluted equity The expiry term from the date of regulatory approval milestone. Expiry Term From The Date Of Regulatory Approval Milestone Expiry term from the date of regulatory approval milestone The fair value of call right at grant date. Fair Value of Call Right at Grant Date Fair value of call right at grant date Payments to Acquire Intangible Assets Annual amount of payment The percentage of annual increase in payment. Percentage Of Annual Increase In Payment Percentage of annual increase in payment The one-time milestone payment on achievement of conditions. One-Time Milestone Payment On Achievement Of Conditions One-time milestone payment on achievement of conditions The minimum value of closing of an issuance of equity for milestone payment. Minimum Value Of Closing Of An Issuance Of Equity For Milestone Payment Minimum value of closing of an issuance of equity for milestone payment The minimum net proceeds from sale of assets for one-time milestone payment. Minimum Net Proceeds From Sale Of Assets For One-Time Milestone Payment Minimum net proceeds from sale of assets for one-time milestone payment The minimum fully diluted shares outstanding for milestone payment. Minimum Fully Diluted Shares Outstanding For Milestone Payment Minimum fully diluted shares outstanding for milestone payment The fully diluted shares exceeded the minimum limit for milestone payment. Fully Diluted Shares Exceeded the Minimum Limit for Milestone Payment Fully diluted shares exceeded the minimum limit for milestone payment The period for payment of milestone payment. Period for payment of Milestone Payment Period for payment of milestone payment The percentage of royalty fee. Percentage of Royalty Fee Percentage of royalty fee The amount of one-time milestone payment. One-time Milestone Payment One-time milestone payment Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Represents the information pertaining to Legacy Zura. Legacy Zura [Member] Legacy Zura Preferred Stock, Convertible, Shares Issuable Number of Class A ordinary shares on conversion Collaborative Arrangement and Arrangement Other than Collaborative [Table] Represents the information pertaining to Z33 Series Seed Preferred Shares Put Right. Z33 Series Seed Preferred Shares Put Right [Member] Shares issuable upon exercise of Z33 Put Right Represent information pertaining to equity incentive plan. Equity Incentive Plan [Member] Equity Incentive Plan Represents the information pertaining to employee stock purchase plan. Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Shares available for grant under ESPP Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Shareholders' Equity Common Stock, Capital Shares Reserved for Future Issuance Shares reserved for issuance Disclosure of derivative warrant liabilities. Derivative Warrant Liabilities [Table] Sale of Stock [Axis] Sale of Stock [Domain] Private Placement [Member] Private Placement Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents information pertaining to redeemable warrant (public warrant) that entitles the holder to purchase shares of common stock subject to adjustment. Public Warrants [Member] Public warrants Represents the information pertaining to Pre-Funded Warrants. Pre-Funded Warrants [Member] Pre-Funded Warrants Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Represents the information pertaining to JATT Acquisition Corp. JATT Acquisition Corp [Member] JATT Acquisition Corp JATT Represents the information pertaining to subscription agreements with PIPE Investors. Subscription agreements with PIPE Investor [Member] Subscription Agreement Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Line items represents the information pertaining to derivative warrant liabilities. DERIVATIVE WARRANT LIABILITIES [Line Items] Warrants Class of Warrant or Right, Outstanding Warrants outstanding Represents the number of warrants exercised or redeemed. Number Of Warrants Exercised Or Redeemed Number of warrants exercised or redeemed Represents the warrants exercisable term from the closing of the business combination in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Warrants and Rights Outstanding Exercisable Term From Closing of Business Combination Warrants exercisable term from the completion of business combination Warrants and Rights Outstanding, Term Public Warrants expiration term Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of Class A ordinary shares upon exercise of each warrant Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants Exercise Price The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Class of Warrant or Right, Minimum Threshold Written Notice Period for Redemption of Warrants Minimum threshold written notice period for redemption of public warrants The per share amount of price of the entity's common stock which would be required to be attained to trigger the redemption of warrants. Class of Warrant or Right Redemption of Warrants or Rights Stock Trigger Price Stock price trigger for redemption of public warrants The per share amount of redemption price per share or per unit of warrants or rights outstanding. Class of Warrant or Right, Redemption Price of Warrants or Rights Redemption price per public warrant (in dollars per share) Threshold number of specified trading days for stock price trigger considered for redemption of warrants in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Class of Warrant or Right, Redemption of Warrants or Rights, , Threshold Trading Days Threshold trading days for redemption of public warrants The number of threshold number of business days before sending notice of redemption to warrant holders. Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders Threshold number of business days before sending notice of redemption to warrant holders The period of time which must elapse after completion of a business combination before the Sponsor can transfer, assign or sell any Founder Shares unless other specified conditions are met in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Threshold Period for Not To Transfer, Assign or Sell Any Shares or Warrants After Completion of Initial Business Combination Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants Issued Number of warrants issued to purchase shares The price per warrant issued. Price per Warrant Issued Price per warrant Sale price per warrant Proceeds from Issuance of Warrants Aggregate purchase price Class of Warrant or Right [Table] Represents the information pertaining to warrants issued 6,899,996 exercise price 11.50. Warrants Issued 6,899,996 Exercise Price 11.50 [Member] Warrant issued 6,899,996 exercise price 11.50 Represents the information pertaining to warrants issued 5,910,000 exercise price 11.50. Warrants Issued 5,910,000 Exercise Price 11.50 [Member] Warrant issued 5,910,000 exercise price 11.50 Represents the information pertaining to warrants issued 3,782,000 exercise price 0.001. Warrants Issued 3,782,000 Exercise Price 0.001 [Member] Warrant issued 3,782,000 exercise price 0.001 Class of Warrant or Right [Line Items] Warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Share based compensation arrangement Represents the percentage of aggregate number of ordinary Shares outstanding. Percentage of Aggregate Number of Ordinary Shares Outstanding Percentage of discount for eligible employees Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of shares issued Granted Weighted-average assumptions used to estimate the fair value Share price for the exchange of the underlying asset relating to the share-based payment award. Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Share Price Share price Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected life Title of Individual [Axis] Title of Individual [Domain] Represent information pertaining to directors, executives, and employees. Directors Executives And Employees [Member] Directors Executives And Employees Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Ending balance Beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Ending balance Beginning balance Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Exercise price of shares granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Options vested and exercisable no definition. Share-Based Compensation Arrangement by Share-Based Payment Award, Weighted Average Remaining Contractual Life [Abstract] Weighted Average Remaining Contractual Life Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Options vested and exercisable No definition. Share-Based Compensation Arrangement by Share-Based Payment Award, Aggregate Intrinsic Value [Abstract] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Options vested and exercisable Share-Based Payment Arrangement, Expense Share-based compensation expense Expense recognized Proceeds from Issuance of Private Placement Proceeds from issuance of Ordinary Shares in connection with April 2023 Private Placement, net of $4.2 million of transaction costs Aggregate purchase price Represents the number of days based on which the weighted average trading price ("VWAP") is determined. Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Vesting, Number of Days Based on Which Volume Weighted Average Trading Price is Determined Period of volume weighted average trading price ("VWAP") Represents the minimum price per share for vesting awards. Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Minimum Price per Share For Vesting of Award Minimum price per share for vesting awards Represents the threshold period of vesting from grant date. Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Threshold Period From Grant Date for Vesting of Awards Threshold period from grant date for vesting awards Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Expiration term (in years) The fair value per share that is used in valuing an option on its own shares. Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Fai Value per Share Fair value per Market-Based Share Options Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Number of RSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Ending balance Beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share based payment award, equity instruments other than options, vested in period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Ending balance Beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested Represents the information pertaining to severance agreement with chief operating officer. Severance Agreement with Chief Operating Officer [Member] Severance agreement Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Share based payment award, options, vested, number of shares Amount of reversal of expense for award under share-based payment arrangement related to modification. Share-Based Payment Arrangement, Expense Reversal Share based payment arrangement, expense reversal Income Statement Location [Axis] Income Statement Location [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized share-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Share-based compensation expense expected to be recognized over a weighted average period Redeemable Noncontrolling Interest, by Legal Entity [Table] Represents information pertaining to Z33 Bio, Inc. Z33 Bio, Inc. [Member] Z33 Represents the information pertaining to Series Seed Preferred Shares. Series Seed Preferred Shares [Member] Series Seed Preferred Shares Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] Call Option [Member] Put Option [Member] Redeemable Noncontrolling Interest [Line Items] Represents the maximum percentage of shares that can be purchased in an option. Maximum Percentage Of Shares That Can Be Purchased In Option Maximum percentage of shares that can be purchased in an option Option Indexed to Issuer's Equity, Strike Price Purchase price per share Represents the term of call option. Option Contract Indexed to Equity, Term Term of call option Represents the settlement term. Option Contract Indexed to Equity, Settlement, Term Settlement term Represents the percentage of shares agreed to purchase upon settlement of call option. Percentage Of Shares Agreed To Purchase Upon Settlement Of Call Option Percentage of shares agreed to purchase upon settlement of call option Option Indexed to Issuer's Equity, Shares Number of shares agreed to issue for settlement Temporary Equity, Dividends, Adjustment Deemed dividend to the redeemable noncontrolling interest Represents the maximum percentage of shares that can be purchased in a put right. Maximum Percentage Of Shares That Can Be Purchased In A Put Right Maximum percentage of shares that can be purchased in a put right Represents the number of shares to be purchased in put right. Number Of Shares To Be Purchased In Put Right Number of shares to be purchased in put right Temporary Equity, Accretion to Redemption Value Deemed contribution from the redeemable noncontrolling interest Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Events Represents information pertaining to April 2024 investor agreements. April 2024 Investor Agreements [Member] April 2024 Investor Agreements Represents information pertaining to April 2024 insider agreements and April 2024 investor agreements. April 2024 Private Placement [Member] April 2024 Private Placement Represents information pertaining to officers, directors and affiliates. Officers, Director And Affiliates [Member] Officers, Director And Affiliates Subsequent Event [Line Items] Subsequent Events Number of warrants issued during the period. Class of Warrant or Right, Number of Warrants Issued Number of warrants issued Shares Issued, Price Per Share Price per share